Todos os estudos
RecrutamentoConfirmatório terapêutico (Fase III)Intervencionista

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Attacks in Adolescents and Adults with Hereditary Angioedema.

This research is looking into a new oral medicine, a soft capsule called deucrictibant, for people who experience Hereditary Angioedema (HAE) attacks. The main goal is to find out how quickly this new medicine can ease symptoms compared to a dummy capsule (placebo) and an existing HAE treatment (icatibant). Participants will take the medicine when they have an attack, and researchers will carefully track how their symptoms improve over time. They want to see if people feel 'a little better' very quickly, and how long it takes for a more significant improvement or for symptoms to completely disappear. The study is for adults and aims to confirm if deucrictibant is an effective and fast-acting treatment for sudden HAE attacks.

Em resumo

Status
Recrutamento
Fase
Confirmatório terapêutico (Fase III)
Patrocinador
Pharvaris Netherlands B.V.
Meta de inscrição
73
Iniciar
16 Jul 2024

Sobre o que é este estudo?

This study is about finding a quicker way to help people who have sudden attacks from a condition called Hereditary Angioedema, or HAE. HAE causes unpredictable swelling attacks, which can be painful and sometimes dangerous. Researchers are testing a new medicine in a soft capsule called deucrictibant.

They want to see if this new medicine can stop an attack quickly and effectively. To do this, they’ll compare it to a dummy capsule (called a placebo, which looks like the real medicine but has no active ingredients) and another existing HAE medicine. This type of study is called a 'crossover study,' which means participants might try different treatments at different times during the study. This helps researchers get a clear picture of how each medicine works.

The main thing the study will measure is how fast people start to feel better after taking the medicine. They’ll look for clear signs of improvement, like feeling 'a little better' for two times in a row within 12 hours of taking the capsule. They will also track how long it takes for symptoms to greatly improve or completely go away, and if participants need other medicines to help with their attack.

Pontos principais

  • Tests a new oral medicine (deucrictibant) for HAE attacks.
  • Compares it to a dummy pill (placebo) and an existing treatment (icatibant).
  • Aims to find out how quickly symptoms of HAE attacks improve.
  • Designed for adults aged 18 and over.
  • Participation helps future HAE treatments.

Quem pode ser elegível?

To be part of this study, you must be an adult, as it is designed for people aged 18 and older. Both men and women can participate. The study is looking for individuals who have been diagnosed with Hereditary Angioedema (HAE) and experience attacks.

There might be other health or medication-related requirements that aren't listed here. These are put in place to ensure your safety and that the study results are clear and accurate. For example, if you have certain other medical conditions or are taking specific medications, you might not be able to join.

Este estudo pode ser adequado para você?

Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.

  1. Você tem 18 anos ou mais?
  2. Have you been diagnosed with Hereditary Angioedema (HAE)?
  3. Do you experience HAE attacks?
  4. Are you able to take medicines by mouth (oral capsules)?
Responda a todas as perguntas para ver o seu resultado.

O que envolve a participação?

If you join this study, you'll be given one of the study medicines (deucrictibant, icatibant, or placebo) to take when you experience an HAE attack. You won't know which one you're taking, nor will the study doctors, until after the study is over. This is called 'double-blind'. You'll then keep track of your symptoms and how you feel, noting down when you start to feel better.

You'll be asked to attend clinic visits to check on your health and discuss your experiences. There will be careful monitoring of your condition and any side effects you might have. The study will involve trying different treatments over time, potentially switching between the active medicine and the dummy capsule. The total time you'd be involved in the study would be explained by the study team.

Riscos e benefícios potenciais

Participating in research always has potential benefits and risks. A potential benefit of this study is that you might receive an active medication that could help ease your HAE attacks. You would also be contributing important information that could help others with HAE in the future. However, there's a chance you might receive a placebo, which wouldn't treat your attack. As with any new medicine, there's a risk of unknown side effects, and known side effects will be explained to you. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Localizações (14)

Algumas localizações dos sites são aproximadas. Estamos melhorando isso — por favor, verifique com a equipe de teste antes de viajar.
  • —
    Não verificado
    Polônia
  • —
    Não verificado
    Alemanha
  • —
    Não verificado
    Áustria
  • —
    Não verificado
    Itália
  • —
    Não verificado
    Suécia
  • —
    Não verificado
    Bulgária
  • —
    Não verificado
    Irlanda
  • —
    Não verificado
    Hungria
  • —
    Não verificado
    Espanha
  • —
    Não verificado
    Países Baixos
  • —
    Não verificado
    Chéquia
  • —
    Não verificado
    França

Perguntas frequentes

What is Hereditary Angioedema (HAE)?

HAE is a rare genetic condition that causes sudden and unpredictable attacks of swelling in different parts of the body, like the hands, feet, face, or airways.

O que é um 'placebo'?

A placebo is a dummy treatment that looks exactly like the real medicine but doesn't contain any active ingredients. It helps researchers understand if the new medicine is truly effective.

O que significa 'duplo-cego'?

Double-blind means that neither you nor your study doctor will know whether you are receiving the new medicine, the existing medicine, or the placebo during the study. This helps make the study fair and unbiased.

Eu terei que pagar para participar do estudo?

No, you will not have to pay for the study medication or any study-related tests or appointments.

What does a 'crossover study' mean?

A crossover study means you might try different treatments at different points over the study period. For example, you might take the new medicine for some attacks and the placebo for others.

Como saber mais

Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.

Interessado em participar?

Registre seu interesse

Compartilhe seus detalhes e a equipe de pesquisa para "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Cro…" entrará em contato com você se você for elegível. Sempre fale com seu médico antes de concordar em participar.

Discussão

Discussão da comunidade

Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.